Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Truffle Capital does not conduct clinical trials itself but has backed numerous successful exits and IPOs in life sciences. Its BioMedTech fund focuses on clinical-stage therapeutic device companies across Europe with a strong track record of supporting innovation from inception through commercialization[1][2][4][9].
Example results from its investments include:
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Truffle Capital.